- 1. 4-dedimethylamino sancycline
- [An anticancer drug that may stop tumor growth by preventing the growth of new blood vessels into a solid tumor. ( NCI )] (UMLS (NCI) C0763138) 4-Dimethlyamino Sancycline;
4-Dimethlyaminosancycline;
6-deoxy, 6-demethyl, 4-de-dimethylamino tetracycline;
6-deoxy-6-demethyl-4-dedimethylaminotetracycline;
CMT-3;
COL 3;
COL-3 =Organic Chemical; Pharmacologic Substance | - 8. Dedifferentiated Chordoma
- [A high-grade malignant bone tumor arising from the remnants of the notochord. It is characterized by a lobulated growth pattern, myxoid stroma formation, the presence of physaliphorous cells, and a sarcomatous component. ( NCI )] (UMLS (NCI) C1266174) Sarcomatoid Chordoma =Neoplastic Process
|
- 2. dedicated service delivery location
- [A role of a place (player) that is intended to house the provision of services. Scoper is the Entity (typically Organization) that provides these services. This is not synonymous with "ownership." ( HL7V3.0 )] (UMLS (HL7) C1554206) health care facility;
=Spatial Concept =service delivery location;
| - 9. Dedifferentiated Dermatofibrosarcoma Protuberans
- [A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of poorly differentiated sarcomatous components. ( NCI )] (UMLS (NCI) C1333264) =Neoplastic Process ;
|
- 3. DedicatedClinicalLocationRoleType
- [A role of a place that further classifies the clinical setting (e.g., cardiology clinic, primary care clinic, rehabilitation hospital, skilled nursing facility) in which care is delivered during an encounter. ( HL7V3.0 )] (UMLS (HL7) C1698333) =Intellectual Product ;
=DedicatedServiceDeliveryLocationRoleType;
=Hospital unit;
Outpatient facility;
Nursing or custodial care facility;
Residential treatment facility;
Diagnostics or therapeutics unit;
Hospital;
| - 10. Dedifferentiated Giant Cell Tumor
- [A high-grade aggressive bone tumor, usually arising in the end of long bones. The tumor is composed of round or oval mononuclear cells, uniformly distributed osteoclast-like giant cells, and a sarcomatous spindle cell component. Clinical presentation includes pain and edema in the affected area. ( NCI )] (UMLS (NCI) C0334552) =Neoplastic Process
|
- 4. DedicatedNonClinicalLocationRoleType
- [A role of a place that further classifies a setting that is intended to house the provision of non-clinical services. ( HL7V3.0 )] (UMLS (HL7) C1698334) =Intellectual Product ;
=DedicatedServiceDeliveryLocationRoleType;
=Delivery Address;
Mobile Unit;
Pharmacy | - 11. Dedifferentiated Liposarcoma
- [A liposarcoma of any histologic subtype mixed with a non-lipomatous, high grade sarcomatous component. The non-lipomatous component may be present in the primary lesion or at the site of metastasis. ( NCI )] (UMLS (NCI) C0205824) =Neoplastic Process ;
|
- 5. DedicatedServiceDeliveryLocationRoleType
- [A role of a place that further classifies a setting that is intended to house the provision of services. ( HL7V3.0 )] (UMLS (HL7) C1699958) =Intellectual Product ;
=ServiceDeliveryLocationRoleType;
=DedicatedClinicalLocationRoleType;
DedicatedNonClinicalLocationRoleType | - 12. deductible
- [That portion of the eligible charges which a covered party must pay in a particular period (e.g. annual) before the benefits are payable by the adjudicator. This amount represents the covered party's deductible that is applied to a particular adjudication result. It is expressed as a negative dollar amount in adjudication results. ( HL7V3.0 )] (UMLS (HL7) C1611291) =Intellectual Product =ActInvoiceDetailGenericAdjudicatorCode;
|
- 6. Dedicator of Cytokinesis 1 Gene
- [This gene is involved in apoptosis, cell motility/migration and phagocytosis. ( NCI )] (UMLS (NCI) C1333245) DOCK1;
DOCK1 Gene;
=Gene or Genome ;
| - 13. Deductible not applicable (specific list of HCPCS codes)
- (UMLS (HL7) C1547516) =Intellectual Product =Payment Adjustment Code;
|
- 7. Dedifferentiated Chondrosarcoma
- [An aggressive morphologic variant of chondrosarcoma. It is composed of a low grade chondrosarcoma, and a high grade non-cartilagenous sarcomatous component. Due to the aggressive nature of the disease, the prognosis is poor. ( NCI )] (UMLS (NCI) C0862878) =Neoplastic Process
| |
home
